ExPASy logo ExPASy Home page Site Map Search ExPASy Contact us Swiss-Prot
Notice: This page will be replaced with www.uniprot.org. Please send us your feedback!
Search for

UniProtKB/Swiss-Prot entry P03317


[Entry info] [Name and origin] [References] [Comments] [Cross-references] [Keywords] [Features] [Sequence] [Tools]

Note: most headings are clickable, even if they don't appear as links. They link to the user manual or other documents.
Entry information
Entry name POLN_SINDV
Primary accession number P03317
Secondary accession numbers None
Integrated into Swiss-Prot on July 21, 1986
Sequence was last modified on July 21, 1986 (Sequence version 1)
Annotations were last modified on    September 2, 2008 (Entry version 79)
Name and origin of the protein
Protein name Non-structural polyprotein
Synonyms Polyprotein nsP1234
P1234
Contains P123
P123'
mRNA-capping enzyme nsP1
     (EC 2.1.1.-)
     (EC 2.7.7.-)
     (Non-structural protein 1)
Protease/triphosphatase/NTPase/helicase nsP2
     (EC 3.4.22.-)
     (EC 3.1.3.33)
     (EC 3.6.1.15)
     (EC 3.6.1.-)
     (Non-structural protein 2)
     (nsP2)
Non-structural protein 3
     (nsP3)
Non-structural protein 3'
     (nsP3')
RNA-directed RNA polymerase nsP4
     (EC 2.7.7.48)
     (Non-structural protein 4)
     (nsP4)
Gene name None
From
Sindbis virus (SINV) [TaxID: 11034] 
Taxonomy Viruses; ssRNA positive-strand viruses, no DNA stage; Togaviridae; Alphavirus; WEEV complex.
Virus hosts Acrocephalus scirpaceus [TaxID: 48156]
Aedes [TaxID: 7158]
Culex [TaxID: 53527]
Homo sapiens (Human) [TaxID: 9606]
Motacilla alba (White wagtail) (Pied wagtail) [TaxID: 45807]
Streptopelia turtur [TaxID: 177155]
Protein existence 1: Evidence at protein level;
References
[1]
NUCLEOTIDE SEQUENCE [GENOMIC RNA].
DOI=10.1016/0042-6822(84)90428-8; PubMed=6322438 [NCBI, ExPASy, EBI, Israel, Japan]
Strauss E.G., Rice C.M., Strauss J.H.;
"Complete nucleotide sequence of the genomic RNA of Sindbis virus.";
Virology 133:92-110(1984).
[2]
NUCLEOTIDE SEQUENCE [GENOMIC RNA] OF 1-54.
DOI=10.1016/S0022-2836(83)80319-2; PubMed=6308269 [NCBI, ExPASy, EBI, Israel, Japan]
Ou J.H., Strauss E.G., Strauss J.H.;
"The 5'-terminal sequences of the genomic RNAs of several alphaviruses.";
J. Mol. Biol. 168:1-15(1983).
[3]
NUCLEOTIDE SEQUENCE [GENOMIC RNA] OF 1429-2512.
PubMed=6577423 [NCBI, ExPASy, EBI, Israel, Japan]
Strauss E.G., Rice C.M., Strauss J.H.;
"Sequence coding for the alphavirus nonstructural proteins is interrupted by an opal termination codon.";
Proc. Natl. Acad. Sci. U.S.A. 80:5271-5275(1983).
[4]
NUCLEOTIDE SEQUENCE [GENOMIC RNA] OF 2431-2512.
PubMed=6291034 [NCBI, ExPASy, EBI, Israel, Japan]
Ou J.-H., Rice C.M., Dalgarno L., Strauss E.G., Strauss J.H.;
"Sequence studies of several alphavirus genomic RNAs in the region containing the start of the subgenomic RNA.";
Proc. Natl. Acad. Sci. U.S.A. 79:5235-5239(1982).
[5]
SUBCELLULAR LOCATION OF NON-STRUCTURAL PROTEINS.
DOI=10.1083/jcb.107.6.2075; PubMed=2904446 [NCBI, ExPASy, EBI, Israel, Japan]
Froshauer S., Kartenbeck J., Helenius A.;
"Alphavirus RNA replicase is located on the cytoplasmic surface of endosomes and lysosomes.";
J. Cell Biol. 107:2075-2086(1988).
[6]
PROTEOLYTIC PROCESSING OF POLYPROTEIN.
PubMed=2529379 [NCBI, ExPASy, EBI, Israel, Japan]
Hardy W.R., Strauss J.H.;
"Processing the nonstructural polyproteins of sindbis virus: nonstructural proteinase is in the C-terminal half of nsP2 and functions both in cis and in trans.";
J. Virol. 63:4653-4664(1989).
[7]
MUTAGENESIS OF OPAL STOP CODON BETWEEN TYR-1896 AND LEU-1897.
PubMed=2521676 [NCBI, ExPASy, EBI, Israel, Japan]
Li G.P., Rice C.M.;
"Mutagenesis of the in-frame opal termination codon preceding nsP4 of Sindbis virus: studies of translational readthrough and its effect on virus replication.";
J. Virol. 63:1326-1337(1989).
[8]
PROTEOLYTIC PROCESSING OF POLYPROTEIN BY NSP2.
PubMed=2142454 [NCBI, ExPASy, EBI, Israel, Japan]
de Groot R.J., Hardy W.R., Shirako Y., Strauss J.H.;
"Cleavage-site preferences of Sindbis virus polyproteins containing the non-structural proteinase. Evidence for temporal regulation of polyprotein processing in vivo.";
EMBO J. 9:2631-2638(1990).
[9]
UBIQUITIN DEGRADATION OF NSP4.
PubMed=1924357 [NCBI, ExPASy, EBI, Israel, Japan]
de Groot R.J., Ruemenapf T., Kuhn R.J., Strauss E.G., Strauss J.H.;
"Sindbis virus RNA polymerase is degraded by the N-end rule pathway.";
Proc. Natl. Acad. Sci. U.S.A. 88:8967-8971(1991).
[10]
MUTAGENESIS OF CYS-1021; HIS-1098 AND TRP-1099.
DOI=10.1016/0042-6822(92)90268-T; PubMed=1448929 [NCBI, ExPASy, EBI, Israel, Japan]
Strauss E.G., De Groot R.J., Levinson R., Strauss J.H.;
"Identification of the active site residues in the nsP2 proteinase of Sindbis virus.";
Virology 191:932-940(1992).
[11]
FUNCTION.
PubMed=7517863 [NCBI, ExPASy, EBI, Israel, Japan]
Lemm J.A., Ruemenapf T., Strauss E.G., Strauss J.H., Rice C.M.;
"Polypeptide requirements for assembly of functional Sindbis virus replication complexes: a model for the temporal regulation of minus- and plus-strand RNA synthesis.";
EMBO J. 13:2925-2934(1994).
[12]
FUNCTION OF P123.
PubMed=8107248 [NCBI, ExPASy, EBI, Israel, Japan]
Shirako Y., Strauss J.H.;
"Regulation of Sindbis virus RNA replication: uncleaved P123 and nsP4 function in minus-strand RNA synthesis, whereas cleaved products from P123 are required for efficient plus-strand RNA synthesis.";
J. Virol. 68:1874-1885(1994).
[13]
MUTAGENESIS OF HIS-39; HIS-81; ASP-91; ARG-94; TYR-249 AND ILE-369.
DOI=10.1006/viro.1996.0147; PubMed=8610444 [NCBI, ExPASy, EBI, Israel, Japan]
Wang H.-L., O'Rear J., Stollar V.;
"Mutagenesis of the Sindbis virus nsP1 protein: effects on methyltransferase activity and viral infectivity.";
Virology 217:527-531(1996).
[14]
MUTAGENESIS OF TYR-1903.
PubMed=9499091 [NCBI, ExPASy, EBI, Israel, Japan]
Shirako Y., Strauss J.H.;
"Requirement for an aromatic amino acid or histidine at the N-terminus of Sindbis virus RNA polymerase.";
J. Virol. 72:2310-2315(1998).
[15]
PALMITOYLATION AT CYS-420, AND MUTAGENESIS OF CYS-420.
DOI=10.1128/JVI.74.15.6725-6733.2000; PubMed=10888610 [NCBI, ExPASy, EBI, Israel, Japan]
Ahola T., Kujala P., Tuittila M., Blom T., Laakkonen P., Hinkkanen A., Auvinen P.;
"Effects of palmitoylation of replicase protein nsP1 on alphavirus infection.";
J. Virol. 74:6725-6733(2000).
[16]
INDUCTION.
DOI=10.1101/gad.357006; PubMed=16391235 [NCBI, ExPASy, EBI, Israel, Japan]
Ventoso I., Sanz M.A., Molina S., Berlanga J.J., Carrasco L., Esteban M.;
"Translational resistance of late alphavirus mRNA to eIF2alpha phosphorylation: a strategy to overcome the antiviral effect of protein kinase PKR.";
Genes Dev. 20:87-100(2006).
Comments
  • FUNCTION: P123 and P123' are short-lived polyproteins, accumulating during early stage of infection. P123 is directly translated from the genome, whereas P123' is a product of the cleavage of P1234. They localize the viral replication complex to the cytoplasmic surface of modified endosomes and lysosomes. By interacting with nsP4, they start viral genome replication into antigenome. After these early events, P123 and P123' are cleaved sequentially into nsP1, nsP2 and nsP3/nsP3'. This sequence of delayed processing would allow correct assembly and membrane association of the RNA polymerase complex.
  • FUNCTION: nsP1 is a cytoplasmic capping enzyme. This function is necessary since all viral RNAs are synthesized in the cytoplasm, and host capping enzymes are restricted to the nucleus. The enzymatic reaction involves a covalent link between 7-methyl-GMP and nsP1, whereas eukaryotic capping enzymes form a covalent complex only with GMP. nsP1 capping would consist in the following reactions: GTP is first methylated and then forms the m7GMp-nsP1 complex, from which 7-methyl-GMP complex is transferred to the mRNA to create the cap structure. Palmitoylated nsP1 is remodeling host cell cytoskeleton, and induces filopodium-like structure formation at the surface of the host cell.
  • FUNCTION: nsP2 has two separate domain with different biological activities. The N-terminal section is part of the RNA polymerase complex and has RNA trisphosphatase and RNA helicase activity. The C-terminal section harbors a protease that specifically cleaves and releases the four mature proteins.
  • FUNCTION: nsP3 and nsP3' are essential for minus strand and subgenomic 26S mRNA synthesis.
  • FUNCTION: nsP4 is a RNA dependent RNA polymerase. It replicates genomic and antigenomic RNA by recognizing replications specific signals. Transcribes also a 26S subgenomic mRNA by initiating RNA synthesis internally on antigenomic RNA. This 26S mRNA encodes for structural proteins. nsP4 is a short-lived protein regulated by several ways: the opal codon readthrough and degradation by ubiquitin pathway.
  • CATALYTIC ACTIVITY: S-adenosyl-L-methionine + GTP = m7GTP.
  • CATALYTIC ACTIVITY: m7GTP + (5')pp-Pur-mRNA = diphosphate + m7G(5')ppp-Pur-mRNA.
  • CATALYTIC ACTIVITY: (5')ppp-mRNA + H2O = (5')pp-mRNA + phosphate.
  • CATALYTIC ACTIVITY: A 5'-phosphopolynucleotide + H2O = a polynucleotide + phosphate.
  • CATALYTIC ACTIVITY: NTP + H2O = NDP + phosphate.
  • CATALYTIC ACTIVITY: Nucleoside triphosphate + RNA(n) = diphosphate + RNA(n+1).
  • SUBUNIT: P123 interacts with nsP4; nsP1, nsP2, nsP3 and nsP4 interact with each other, and with uncharacterized host factors.
  • SUBCELLULAR LOCATION: Non-structural polyprotein: Endosome membrane; Peripheral membrane protein; Cytoplasmic side. Lysosome membrane; Peripheral membrane protein; Cytoplasmic side. Note=Located on the cytoplasmic surface of modified endosomes and lysosomes, also called cytopathic vacuoles type I (CPVI). These vacuoles contain numerous small circular invaginations (spherules) which may be the sites of RNA synthesis.
  • SUBCELLULAR LOCATION: P123: Endosome membrane; Peripheral membrane protein; Cytoplasmic side. Lysosome membrane; Peripheral membrane protein; Cytoplasmic side.
  • SUBCELLULAR LOCATION: P123': Endosome membrane; Peripheral membrane protein; Cytoplasmic side. Lysosome membrane; Peripheral membrane protein; Cytoplasmic side.
  • SUBCELLULAR LOCATION: mRNA-capping enzyme nsP1: Endosome membrane; Peripheral membrane protein; Cytoplasmic side. Lysosome membrane; Peripheral membrane protein; Cytoplasmic side. Cell membrane; Peripheral membrane protein; Cytoplasmic side. Cell projection, filopodium. Note=In the late phase of infection, the polyprotein is quickly cleaved before localization to cellular membranes. Then a fraction of nsP1 localizes to the inner surface of the plasma membrane and its filopodial extensions.
  • SUBCELLULAR LOCATION: Protease/triphosphatase/NTPase/helicase nsP2: Endosome membrane; Peripheral membrane protein; Cytoplasmic side. Lysosome membrane; Peripheral membrane protein; Cytoplasmic side. Nucleus. Note=In the late phase of infection, the polyprotein is quickly cleaved before localization to cellular membranes. Then approximately half of nsP2 is found in the nucleus.
  • SUBCELLULAR LOCATION: Non-structural protein 3: Endosome membrane; Peripheral membrane protein; Cytoplasmic side. Lysosome membrane; Peripheral membrane protein; Cytoplasmic side. Cytoplasm. Note=In the late phase of infection, the polyprotein is quickly cleaved before localization to cellular membranes. Then nsP3 and nsP3' seems to aggregate in cytoplasm.
  • SUBCELLULAR LOCATION: Non-structural protein 3': Endosome membrane; Peripheral membrane protein; Cytoplasmic side. Lysosome membrane; Peripheral membrane protein; Cytoplasmic side. Cytoplasm. Note=In the late phase of infection, the polyprotein is quickly cleaved before localization to cellular membranes. Then nsP3 and nsP3' seems to aggregate in cytoplasm.
  • SUBCELLULAR LOCATION: RNA-directed RNA polymerase nsP4: Endosome membrane; Peripheral membrane protein; Cytoplasmic side. Lysosome membrane; Peripheral membrane protein; Cytoplasmic side.
  • INDUCTION: Viral replication produces dsRNA in the late phase of infection, resulting in a strong activation of host EIF2AK2/PKR, leading to almost complete phosphorylation of EIF2A. This inactivates completely cellular translation initiation, resulting in a dramatic shutoff of proteins synthesis. Translation of viral non-structural polyprotein and all cellular proteins are stopped in infected cell between 2 and 4 hours post infection. Only the 26S mRNA is still translated into viral structural proteins, presumably through a unique mechanism of enhancer element which counteract the translation inhibition mediated by EIF2A. By doing this, the virus uses the cellular defense for its own advantage: shutoff of cellular translation allows to produce big amounts of structural proteins needed for the virus to bud out of the doomed cell.
  • PTM: Specific enzymatic cleavages in vivo yield mature proteins. The polyprotein is synthesized as P123, or P1234 by stop codon readthrough. These polyproteins are processed differently depending on the stage of infection. In early stages, P1234 is first cleaved in trans, through its nsP2 protease activity, releasing P123' and nsP4. P123/P123' and nsP4 start to replicate the viral genome into its antigenome. After these early events, nsP1 is cleaved in cis by nsP2 protease, releasing the P23/P23' polyprotein. Cleavage of nsP1 exposes an 'activator' at the N-terminus of P23/P23' which induces its cleavage into nsP2 and nsP3 by the viral protease. This sequence of delayed processing would allow correct assembly and membrane association of the RNA-polymerase complex. In the late stage of infection, the presence of free nsP2 in the cytoplasm cleaves P1234 quickly into P12 and P34, then into the four nsP.
  • PTM: nsP1 is palmitoylated by host.
  • PTM: nsP4 is ubiquitinated; targets the protein for rapid degradation via the ubiquitin system.
  • MISCELLANEOUS: The genome encodes for P123, but readthrough of a terminator codon UGA occurs between the codons for Tyr-1896 and Leu-1897. This readthrough produces P1234, cleaved quickly by nsP2 into P123' and nsP4. Further processing of p123' gives nsP1, nsP2 and nsP3' which is 6 amino-acids longer than nsP3 since the cleavage site is after the readthrough. This unusual molecular mechanism ensures that few nsP4 are produced compared to other non-structural proteins. Mutant viruses with no alternative termination site grow significantly slower than wild-type virus.
  • SIMILARITY: Contains 1 Macro domain.
  • SIMILARITY: Contains 1 peptidase C9 domain [view classification].
  • SIMILARITY: Contains 1 RdRp catalytic domain.
Copyright
Copyrighted by the UniProt Consortium, see http://www.uniprot.org/terms. Distributed under the Creative Commons Attribution-NoDerivs License.
Cross-references
Sequence databases
EMBL
J02363; AAA96975.1; ALT_SEQ; Genomic_RNA.[EMBL / GenBank / DDBJ] [CoDingSequence]
PIR A03917; MNWVS.
RefSeq NP_062889.1; -.
3D structure databases
HSSP P08411; 1FW5. [HSSP ENTRY / PDB]
ModBase P03317.
Protein family/group databases
MEROPS C09.001; -.
Ontologies
GO
GO:0005765; Cellular component: lysosomal membrane (inferred from electronic annotation from UniProtKB-SubCell).
QuickGo view.
Family and domain databases
InterPro IPR002589; A1pp.
IPR002620; Peptidase_C9.
IPR001788; RNA-dep_RNA_pol_vir-typ.
IPR000606; RNA_helicase1_vir.
IPR007094; RNA_pol_PSvir.
Graphical view of domain structure.
Pfam PF01661; A1pp; 1.
PF01707; Peptidase_C9; 1.
PF00978; RdRP_2; 1.
PF01443; Viral_helicase1; 1.
Pfam graphical view of domain structure.
SMART SM00506; A1pp; 1.
SMART graphical view of domain structure.
PROSITE PS51154; MACRO; 1.
PS50507; RDRP_SSRNA_POS; 1.
PROSITE graphical view of domain structure (profiles).
BLOCKS P03317.
Genome annotation databases
GeneID 1502154; -.
Other
ProtoNet P03317.
UniRef View cluster of proteins with at least 50% / 90% / 100% identity.
Keywords
ATP-binding; Cell membrane; Cell projection; Cytoplasm; Endosome; Helicase; Hydrolase; Lipoprotein; Lysosome; Membrane; Methyltransferase; mRNA capping; mRNA processing; Multifunctional enzyme; Nucleotide-binding; Nucleotidyltransferase; Nucleus; Palmitate; Phosphoprotein; Protease; RNA replication; RNA-binding; RNA-directed RNA polymerase; Thiol protease; Transferase; Ubl conjugation.
Features
SEVIEWER logo Feature table viewer FT aligner logo Feature aligner
KeyFrom    To Length Description FTId
CHAIN   1   2512  2512     Non-structural polyprotein. PRO_0000308405
CHAIN   1   1902  1902     P123'. PRO_0000227771
CHAIN   1   1896  1896     P123. PRO_0000227772
CHAIN   1    540  540     mRNA-capping enzyme nsP1. PRO_0000041236
CHAIN   541   1347  807     Protease/triphosphatase/NTPase/helicase nsP2. PRO_0000041237
CHAIN   1348   1902  555     Non-structural protein 3'. PRO_0000041238
CHAIN   1348   1896  549     Non-structural protein 3. PRO_0000227773
CHAIN   1903   2512  610     RNA-directed RNA polymerase nsP4. PRO_0000041239
DOMAIN   972   1179  208     Peptidase C9. 
DOMAIN   1348   1507  160     Macro. 
DOMAIN   2266   2381  116     RdRp catalytic. 
NP_BIND   726    733  8     ATP (Potential). 
REGION   245    264  20     nsP1 membrane-binding (By similarity). 
REGION   1013   1032  20     Nucleolus localization signal (By similarity). 
MOTIF   1196   1200  5     Nuclear localization signal (By similarity). 
ACT_SITE   1021   1021        For cysteine protease nsP2 activity. 
ACT_SITE   1098   1098        For cysteine protease nsP2 activity. 
SITE   540    541  2     Cleavage; by nsP2. 
SITE   1347   1348  2     Cleavage; by nsP2. 
SITE   1902   1903  2     Cleavage; by nsP2. 
LIPID   420    420        S-palmitoyl cysteine; by host. 
MUTAGEN   39     39        H->A: Complete loss of methyl transferase activity or viral infectivity. 
MUTAGEN   81     81        H->A: Complete loss of methyl transferase activity or viral infectivity. 
MUTAGEN   91     91        D->A: Complete loss of methyl transferase activity or viral infectivity. 
MUTAGEN   94     94        R->A: Complete loss of methyl transferase activity or viral infectivity. 
MUTAGEN   249    249        Y->A: Complete loss of methyl transferase activity or viral infectivity. 
MUTAGEN   369    369        I->V: No effect on methyl transferase activity or viral infectivity. 
MUTAGEN   420    420        C->A: Complete loss of palmitoylation. 
MUTAGEN   1021   1021        C->A: Complete loss of nsP2 protease activity. 
MUTAGEN   1098   1098        H->A: Complete loss of nsP2 protease activity. 
MUTAGEN   1099   1099        W->A: Complete loss of nsP2 protease activity. 
MUTAGEN   1896   1896        Y->YR,YS,YW: Reduces RNA synthesis in early phase of infection. 
MUTAGEN   1903   1903        Y->A: No effect on nsP4 cleavage. 
MUTAGEN   1903   1903        Y->C: Destabilizes nsP4. 
MUTAGEN   1903   1903        Y->E: Reduces nsP4 cleavage. 
MUTAGEN   1903   1903        Y->F: Destabilizes nsP4. 
MUTAGEN   1903   1903        Y->L: Reduces nsP4 cleavage and destabilizes nsP4. 
MUTAGEN   1903   1903        Y->M: Reduces nsP4 cleavage. 
MUTAGEN   1903   1903        Y->N: Reduces nsP4 cleavage. 
MUTAGEN   1903   1903        Y->P: Complete loss of nsP4 cleavage. 
MUTAGEN   1903   1903        Y->Q: Reduces nsP4 cleavage. 
MUTAGEN   1903   1903        Y->R: Destabilizes nsP4. 
MUTAGEN   1903   1903        Y->T: Reduces nsP4 cleavage. 
Sequence information
Length: 2512 AA [This is the length of the unprocessed precursor] Molecular weight: 279549 Da [This is the MW of the unprocessed precursor] CRC64: F3656FC8BB495726 [This is a checksum on the sequence]
        10         20         30         40         50         60 
MEKPVVNVDV DPQSPFVVQL QKSFPQFEVV AQQVTPNDHA NARAFSHLAS KLIELEVPTT 

        70         80         90        100        110        120 
ATILDIGSAP ARRMFSEHQY HCVCPMRSPE DPDRMMKYAS KLAEKACKIT NKNLHEKIKD 

       130        140        150        160        170        180 
LRTVLDTPDA ETPSLCFHND VTCNMRAEYS VMQDVYINAP GTIYHQAMKG VRTLYWIGFD 

       190        200        210        220        230        240 
TTQFMFSAMA GSYPAYNTNW ADEKVLEARN IGLCSTKLSE GRTGKLSIMR KKELKPGSRV 

       250        260        270        280        290        300 
YFSVGSTLYP EHRASLQSWH LPSVFHLNGK QSYTCRCDTV VSCEGYVVKK ITISPGITGE 

       310        320        330        340        350        360 
TVGYAVTHNS EGFLLCKVTD TVKGERVSFP VCTYIPATIC DQMTGIMATD ISPDDAQKLL 

       370        380        390        400        410        420 
VGLNQRIVIN GRTNRNTNTM QNYLLPIIAQ GFSKWAKERK DDLDNEKMLG TRERKLTYGC 

       430        440        450        460        470        480 
LWAFRTKKVH SFYRPPGTQT CVKVPASFSA FPMSSVWTTS LPMSLRQKLK LALQPKKEEK 

       490        500        510        520        530        540 
LLQVSEELVM EAKAAFEDAQ EEARAEKLRE ALPPLVADKG IEAAAEVVCE VEGLQADIGA 

       550        560        570        580        590        600 
ALVETPRGHV RIIPQANDRM IGQYIVVSPN SVLKNAKLAP AHPLADQVKI ITHSGRSGRY 

       610        620        630        640        650        660 
AVEPYDAKVL MPAGGAVPWP EFLALSESAT LVYNEREFVN RKLYHIAMHG PAKNTEEEQY 

       670        680        690        700        710        720 
KVTKAELAET EYVFDVDKKR CVKKEEASGL VLSGELTNPP YHELALEGLK TRPAVPYKVE 

       730        740        750        760        770        780 
TIGVIGTPGS GKSAIIKSTV TARDLVTSGK KENCREIEAD VLRLRGMQIT SKTVDSVMLN 

       790        800        810        820        830        840 
GCHKAVEVLY VDEAFACHAG ALLALIAIVR PRKKVVLCGD PMQCGFFNMM QLKVHFNHPE 

       850        860        870        880        890        900 
KDICTKTFYK YISRRCTQPV TAIVSTLHYD GKMKTTNPCK KNIEIDITGA TKPKPGDIIL 

       910        920        930        940        950        960 
TCFRGWVKQL QIDYPGHEVM TAAASQGLTR KGVYAVRQKV NENPLYAITS EHVNVLLTRT 

       970        980        990       1000       1010       1020 
EDRLVWKTLQ GDPWIKQPTN IPKGNFQATI EDWEAEHKGI IAAINSPTPR ANPFSCKTNV 

      1030       1040       1050       1060       1070       1080 
CWAKALEPIL ATAGIVLTGC QWSELFPQFA DDKPHSAIYA LDVICIKFFG MDLTSGLFSK 

      1090       1100       1110       1120       1130       1140 
QSIPLTYHPA DSARPVAHWD NSPGTRKYGY DHAIAAELSR RFPVFQLAGK GTQLDLQTGR 

      1150       1160       1170       1180       1190       1200 
TRVISAQHNL VPVNRNLPHA LVPEYKEKQP GPVKKFLNQF KHHSVLVVSE EKIEAPRKRI 

      1210       1220       1230       1240       1250       1260 
EWIAPIGIAG ADKNYNLAFG FPPQARYDLV FINIGTKYRN HHFQQCEDHA ATLKTLSRSA 

      1270       1280       1290       1300       1310       1320 
LNCLNPGGTL VVKSYGYADR NSEDVVTALA RKFVRVSAAR PDCVSSNTEM YLIFRQLDNS 

      1330       1340       1350       1360       1370       1380 
RTRQFTPHHL NCVISSVYEG TRDGVGAAPS YRTKRENIAD CQEEAVVNAA NPLGRPGEGV 

      1390       1400       1410       1420       1430       1440 
CRAIYKRWPT SFTDSATETG TARMTVCLGK KVIHAVGPDF RKHPEAEALK LLQNAYHAVA 

      1450       1460       1470       1480       1490       1500 
DLVNEHNIKS VAIPLLSTGI YAAGKDRLEV SLNCLTTALD RTDADVTIYC LDKKWKERID 

      1510       1520       1530       1540       1550       1560 
AALQLKESVT ELKDEDMEID DELVWIHPDS CLKGRKGFST TKGKLYSYFE GTKFHQAAKD 

      1570       1580       1590       1600       1610       1620 
MAEIKVLFPN DQESNEQLCA YILGETMEAI REKCPVDHNP SSSPPKTLPC LCMYAMTPER 

      1630       1640       1650       1660       1670       1680 
VHRLRSNNVK EVTVCSSTPL PKHKIKNVQK VQCTKVVLFN PHTPAFVPAR KYIEVPEQPT 

      1690       1700       1710       1720       1730       1740 
APPAQAEEAP EVVATPSPST ADNTSLDVTD ISLDMDDSSE GSLFSSFSGS DNSITSMDSW 

      1750       1760       1770       1780       1790       1800 
SSGPSSLEIV DRRQVVVADV HAVQEPAPIP PPRLKKMARL AAARKEPTPP ASNSSESLHL 

      1810       1820       1830       1840       1850       1860 
SFGGVSMSLG SIFDGETARQ AAVQPLATGP TDVPMSFGSF SDGEIDELSR RVTESEPVLF 

      1870       1880       1890       1900       1910       1920 
GSFEPGEVNS IISSRSAVSF PLRKQRRRRR SRRTEYLTGV GGYIFSTDTG PGHLQKKSVL 

      1930       1940       1950       1960       1970       1980 
QNQLTEPTLE RNVLERIHAP VLDTSKEEQL KLRYQMMPTE ANKSRYQSRK VENQKAITTE 

      1990       2000       2010       2020       2030       2040 
RLLSGLRLYN SATDQPECYK ITYPKPLYSS SVPANYSDPQ FAVAVCNNYL HENYPTVASY 

      2050       2060       2070       2080       2090       2100 
QITDEYDAYL DMVDGTVACL DTATFCPAKL RSYPKKHEYR APNIRSAVPS AMQNTLQNVL 

      2110       2120       2130       2140       2150       2160 
IAATKRNCNV TQMRELPTLD SATFNVECFR KYACNDEYWE EFARKPIRIT TEFVTAYVAR 

      2170       2180       2190       2200       2210       2220 
LKGPKAAALF AKTYNLVPLQ EVPMDRFVMD MKRDVKVTPG TKHTEERPKV QVIQAAEPLA 

      2230       2240       2250       2260       2270       2280 
TAYLCGIHRE LVRRLTAVLL PNIHTLFDMS AEDFDAIIAE HFKQGDPVLE TDIASFDKSQ 

      2290       2300       2310       2320       2330       2340 
DDAMALTGLM ILEDLGVDQP LLDLIECAFG EISSTHLPTG TRFKFGAMMK SGMFLTLFVN 

      2350       2360       2370       2380       2390       2400 
TVLNVVIASR VLEERLKTSR CAAFIGDDNI IHGVVSDKEM AERCATWLNM EVKIIDAVIG 

      2410       2420       2430       2440       2450       2460 
ERPPYFCGGF ILQDSVTSTA CRVADPLKRL FKLGKPLPAD DEQDEDRRRA LLDETKAWFR 

      2470       2480       2490       2500       2510 
VGITGTLAVA VTTRYEVDNI TPVLLALRTF AQSKRAFQAI RGEIKHLYGG PK 

P03317 in FASTA format

View entry in original UniProtKB/Swiss-Prot format
View entry in raw text format (no links)
Report form for errors/updates in this UniProtKB/Swiss-Prot entry

BLAST logo BLAST submission on ExPASy/SIB
or at NCBI (USA)
Tools Sequence analysis tools: ProtParam, ProtScale, Compute pI/Mw, PeptideMass, PeptideCutter, Dotlet (Java)
PROSITE logo ScanProsite, MotifScan SWISS-MODEL Submit a homology modeling request to SWISS-MODEL
NPSA logo NPSA Sequence analysis tools

ExPASy logo ExPASy Home page Site Map Search ExPASy Contact us Swiss-Prot
 Hosted by ch flag SIB Switzerland Mirror sites: Australia  Brazil  Canada  China  Korea
Notice: This page will be replaced with www.uniprot.org. Please send us your feedback!